Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H19NO2 |
| Molecular Weight | 221.2955 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(O[C@H]2CCNC[C@H]2O)=C1C
InChI
InChIKey=ZHFIAFNZGWCLHU-YPMHNXCESA-N
InChI=1S/C13H19NO2/c1-9-4-3-5-12(10(9)2)16-13-6-7-14-8-11(13)15/h3-5,11,13-15H,6-8H2,1-2H3/t11-,13+/m1/s1
| Molecular Formula | C13H19NO2 |
| Molecular Weight | 221.2955 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ifoxetine was developed as an unusual drug that specifically and selectively blocks the 5-HT reuptake in the brain without affecting the 5-HT uptake processes in the periphery (blood platelets). The drug was undergoing phase II clinical trials for the treatment of depression; however, the study was suspended.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A case of small cell carcinoma of the kidney. | 2007-04 |
|
| First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs. | 1987-07 |
|
| Ifoxetine, a compound with atypical effects on serotonin uptake. | 1986-10-14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:33 GMT 2025
by
admin
on
Mon Mar 31 18:48:33 GMT 2025
|
| Record UNII |
LHH887104B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C65884
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
71971
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
SUB08126MIG
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
100000083701
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
LHH887104B
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
66208-11-5
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
DTXSID10216397
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
Ifoxetine
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2218865
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
C046382
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY | |||
|
5805
Created by
admin on Mon Mar 31 18:48:33 GMT 2025 , Edited by admin on Mon Mar 31 18:48:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
